Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: A report from the children's cancer group

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 527-535

  Uckun, Fatih M ^a   Sensel, Martha G ^a   Sather, Harland N ^a   Gaynon, Paul S ^a   Arthur, Diane C ^a   Lange, Beverly J ^a   Steinherz, Peter G ^a   Kraft, Peter ^a   Hutchinson, Raymond ^a   Nachman, James B ^a   Reaman, Gregory H ^a   Heerema, Nyla A ^a  

^a St Paul   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER SURVIVAL; CHILD; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 19; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031918423     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.527     Document Type: Article

References (36)

1. Williams DL, Harber J, Murphy SB, et al: Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205-212, 1986
2. Uckun FM, Gajl Peczalska KJ, Provisor AJ, et al: Immunopheno-type-karyotype associations in human acute lymphoblastic leukemia. Blood 73:271-280, 1989
3. Pui CH, Crist WM, Look AT: Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76:1449-1463, 1990
4. Carroll AJ, Crist WM, Parmley RT, et al: Pre-B-cell leukemia associated with chromosome translocation 1;19. Blood 63:721-724, 1984
5. Crist WM, Carroll AJ, Shuster JJ, et al: Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A Pediatric Oncology Group Study. Blood 76:117-122, 1990
6. Pui CH, Williams DL, Kalwinsky DK, et al: Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia. Blood 67:1688-1692, 1986
7. Shikano T, Kaneko Y, Takazawa M, et al: Balanced and unbalanced 1;19 translocation-associated acute lymphoblastic leukemias. Cancer 58:2239-2243, 1986
8. Privitera E, Kamps MP, Hayashi Y, et al: Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 79:1781-1788, 1992
9. Secker-Walker LM, Berger R, Fenaux P, et al: Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 6:363-369, 1992
10. Raimondi SC, Behm FG, Roberson PK, et al: Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 8:1380-1388, 1990
11. Mellentin JD, Nourse J, Hunger SP, et al: Molecular analysis of the t(1;19) breakpoint cluster region in pre-B-cell acute lymphoblastic leukemias. Genes Chromosom Cancer 2:239-247, 1990
12. Hunger SP, Galili N, Carroll AJ, et al: The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 77:687-693, 1991
13. Mellentin JD, Murre C, Donlon TA, et al: The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 246:379-382, 1989
14. Kamps MP, Murre C, Sun XH, et al: A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547-555, 1990
15. Lu Q, Kamps MP: Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: Proposal for a model of a Pbx1-Hox-DNA complex. Mol Cell Biol 16:1632-1640, 1996
16. Nourse J, Mellentin JD, Galili N, et al: Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535-545, 1990
17. Lu Q, Wright DD, Kamps MP: Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 14:3938-3948, 1994
18. Kamps MP, Look AT, Baltimore D: The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 5:358-368, 1991
19. Kamps MP, Wright DD: Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene 9:3159-3166, 1994
20. Pui CH, Raimondi SC, Hancock ML, et al: Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 12:2601-2606, 1994
21. Uckun FM, Downing JR, Gunther R, et al: Human t(1;19)(q23; p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 81:3052-3062, 1993
22. Smith M, Arthur D, Camitta B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18-24, 1996
23. Steinherz PG, Siegel SE, Bleyer WA, et al: Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer 68:751-758, 1991
24. Heerema NA, Palmer CG, Baehner RL: Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. Cancer Genet Cytogenet 17:165-179, 1985
25. Mitelman F: ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzwerland, Karger, 1995
26. Uckun FM, Muraguchi A, Ledbetter JA, et al: Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000-1015, 1989
27. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
28. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
29. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-8, 1977
30. Cox DR: Regression models and life tables. Royal Stat Soc B 34:187-220, 1972
31. Borowitz MJ, Hunger SP, Carroll AJ, et al: Predictability of the t(1;19)(q23;pq13) from surface antigen phenotype: Implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: A Pediatric Oncology Group study. Blood 82:1086-1091, 1993
32. Pui CH, Behm FG, Singh B, et al: Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 75:174-179, 1990
33. Pui CH, Carroll AJ, Raimondi SC, et al: Isochromosomes in childhood acute lymphoblastic leukemia: A collaborative study of 83 cases. Blood 79:2384-2391, 1992
34. Groupe Francais de Cytogenetique Hematologique: Collaborative study of karyotypes in childhood lymphoblastic leukemias. Leukemia 7:10-19, 1993
35. Uckun F, Reaman G, Steinherz P, et al: Improved outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group study. Leuk Lymphoma 24:57-70, 1996
36. Uckun FM, Sather HN, Gaynon PS, et al: Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 90:28-35, 1997